Global Opioids Drug Market Analysis and Forecast 2024-2030
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
According to APO Research, The global Opioids Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report presents an overview of global market for Opioids Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Opioids Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Opioids Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioids Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Opioids Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Opioids Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer and INSYS, etc.
Opioids Drug segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioids Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Opioids Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioids Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global Opioids Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report presents an overview of global market for Opioids Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Opioids Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Opioids Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioids Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Opioids Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Opioids Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer and INSYS, etc.
Opioids Drug segment by Company
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Pain Relief
- Anesthesia
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioids Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Opioids Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioids Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Opioids Drug Market by Type
1.2.1 Global Opioids Drug Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Opioids Drug Market by Application
1.3.1 Global Opioids Drug Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 OPIOIDS DRUG MARKET DYNAMICS
2.1 Opioids Drug Industry Trends
2.2 Opioids Drug Industry Drivers
2.3 Opioids Drug Industry Opportunities and Challenges
2.4 Opioids Drug Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Opioids Drug Revenue Estimates and Forecasts (2019-2030)
3.2 Global Opioids Drug Revenue by Region
3.2.1 Global Opioids Drug Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Opioids Drug Revenue by Region (2019-2024)
3.2.3 Global Opioids Drug Revenue by Region (2025-2030)
3.2.4 Global Opioids Drug Revenue Market Share by Region (2019-2030)
3.3 Global Opioids Drug Sales Estimates and Forecasts 2019-2030
3.4 Global Opioids Drug Sales by Region
3.4.1 Global Opioids Drug Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Opioids Drug Sales by Region (2019-2024)
3.4.3 Global Opioids Drug Sales by Region (2025-2030)
3.4.4 Global Opioids Drug Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Opioids Drug Revenue by Manufacturers
4.1.1 Global Opioids Drug Revenue by Manufacturers (2019-2024)
4.1.2 Global Opioids Drug Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Opioids Drug Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Opioids Drug Sales by Manufacturers
4.2.1 Global Opioids Drug Sales by Manufacturers (2019-2024)
4.2.2 Global Opioids Drug Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Opioids Drug Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Opioids Drug Sales Price by Manufacturers (2019-2024)
4.4 Global Opioids Drug Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Opioids Drug Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Opioids Drug Manufacturers, Product Type & Application
4.7 Global Opioids Drug Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Opioids Drug Market CR5 and HHI
4.8.2 2023 Opioids Drug Tier 1, Tier 2, and Tier
5 OPIOIDS DRUG MARKET BY TYPE
5.1 Global Opioids Drug Revenue by Type
5.1.1 Global Opioids Drug Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Opioids Drug Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Opioids Drug Revenue Market Share by Type (2019-2030)
5.2 Global Opioids Drug Sales by Type
5.2.1 Global Opioids Drug Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Opioids Drug Sales by Type (2019-2030) & (M Units)
5.2.3 Global Opioids Drug Sales Market Share by Type (2019-2030)
5.3 Global Opioids Drug Price by Type
6 OPIOIDS DRUG MARKET BY APPLICATION
6.1 Global Opioids Drug Revenue by Application
6.1.1 Global Opioids Drug Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Opioids Drug Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Opioids Drug Revenue Market Share by Application (2019-2030)
6.2 Global Opioids Drug Sales by Application
6.2.1 Global Opioids Drug Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Opioids Drug Sales by Application (2019-2030) & (M Units)
6.2.3 Global Opioids Drug Sales Market Share by Application (2019-2030)
6.3 Global Opioids Drug Price by Application
7 COMPANY PROFILES
7.1 Teva
7.1.1 Teva Comapny Information
7.1.2 Teva Business Overview
7.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Teva Opioids Drug Product Portfolio
7.1.5 Teva Recent Developments
7.2 Purdue Pharma
7.2.1 Purdue Pharma Comapny Information
7.2.2 Purdue Pharma Business Overview
7.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Purdue Pharma Opioids Drug Product Portfolio
7.2.5 Purdue Pharma Recent Developments
7.3 Mallinckrodt
7.3.1 Mallinckrodt Comapny Information
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mallinckrodt Opioids Drug Product Portfolio
7.3.5 Mallinckrodt Recent Developments
7.4 Amneal Pharma
7.4.1 Amneal Pharma Comapny Information
7.4.2 Amneal Pharma Business Overview
7.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Amneal Pharma Opioids Drug Product Portfolio
7.4.5 Amneal Pharma Recent Developments
7.5 Collegium
7.5.1 Collegium Comapny Information
7.5.2 Collegium Business Overview
7.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Collegium Opioids Drug Product Portfolio
7.5.5 Collegium Recent Developments
7.6 J&J
7.6.1 J&J Comapny Information
7.6.2 J&J Business Overview
7.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 J&J Opioids Drug Product Portfolio
7.6.5 J&J Recent Developments
7.7 Endo
7.7.1 Endo Comapny Information
7.7.2 Endo Business Overview
7.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Endo Opioids Drug Product Portfolio
7.7.5 Endo Recent Developments
7.8 Pfizer
7.8.1 Pfizer Comapny Information
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Pfizer Opioids Drug Product Portfolio
7.8.5 Pfizer Recent Developments
7.9 INSYS
7.9.1 INSYS Comapny Information
7.9.2 INSYS Business Overview
7.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 INSYS Opioids Drug Product Portfolio
7.9.5 INSYS Recent Developments
7.10 Mylan
7.10.1 Mylan Comapny Information
7.10.2 Mylan Business Overview
7.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Mylan Opioids Drug Product Portfolio
7.10.5 Mylan Recent Developments
7.11 Hikma
7.11.1 Hikma Comapny Information
7.11.2 Hikma Business Overview
7.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Hikma Opioids Drug Product Portfolio
7.11.5 Hikma Recent Developments
7.12 Egalet
7.12.1 Egalet Comapny Information
7.12.2 Egalet Business Overview
7.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Egalet Opioids Drug Product Portfolio
7.12.5 Egalet Recent Developments
8 NORTH AMERICA
8.1 North America Opioids Drug Market Size by Type
8.1.1 North America Opioids Drug Revenue by Type (2019-2030)
8.1.2 North America Opioids Drug Sales by Type (2019-2030)
8.1.3 North America Opioids Drug Price by Type (2019-2030)
8.2 North America Opioids Drug Market Size by Application
8.2.1 North America Opioids Drug Revenue by Application (2019-2030)
8.2.2 North America Opioids Drug Sales by Application (2019-2030)
8.2.3 North America Opioids Drug Price by Application (2019-2030)
8.3 North America Opioids Drug Market Size by Country
8.3.1 North America Opioids Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Opioids Drug Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Opioids Drug Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Opioids Drug Market Size by Type
9.1.1 Europe Opioids Drug Revenue by Type (2019-2030)
9.1.2 Europe Opioids Drug Sales by Type (2019-2030)
9.1.3 Europe Opioids Drug Price by Type (2019-2030)
9.2 Europe Opioids Drug Market Size by Application
9.2.1 Europe Opioids Drug Revenue by Application (2019-2030)
9.2.2 Europe Opioids Drug Sales by Application (2019-2030)
9.2.3 Europe Opioids Drug Price by Application (2019-2030)
9.3 Europe Opioids Drug Market Size by Country
9.3.1 Europe Opioids Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Opioids Drug Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Opioids Drug Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Opioids Drug Market Size by Type
10.1.1 China Opioids Drug Revenue by Type (2019-2030)
10.1.2 China Opioids Drug Sales by Type (2019-2030)
10.1.3 China Opioids Drug Price by Type (2019-2030)
10.2 China Opioids Drug Market Size by Application
10.2.1 China Opioids Drug Revenue by Application (2019-2030)
10.2.2 China Opioids Drug Sales by Application (2019-2030)
10.2.3 China Opioids Drug Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Opioids Drug Market Size by Type
11.1.1 Asia Opioids Drug Revenue by Type (2019-2030)
11.1.2 Asia Opioids Drug Sales by Type (2019-2030)
11.1.3 Asia Opioids Drug Price by Type (2019-2030)
11.2 Asia Opioids Drug Market Size by Application
11.2.1 Asia Opioids Drug Revenue by Application (2019-2030)
11.2.2 Asia Opioids Drug Sales by Application (2019-2030)
11.2.3 Asia Opioids Drug Price by Application (2019-2030)
11.3 Asia Opioids Drug Market Size by Country
11.3.1 Asia Opioids Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Opioids Drug Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Opioids Drug Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Opioids Drug Market Size by Type
12.1.1 MEALA Opioids Drug Revenue by Type (2019-2030)
12.1.2 MEALA Opioids Drug Sales by Type (2019-2030)
12.1.3 MEALA Opioids Drug Price by Type (2019-2030)
12.2 MEALA Opioids Drug Market Size by Application
12.2.1 MEALA Opioids Drug Revenue by Application (2019-2030)
12.2.2 MEALA Opioids Drug Sales by Application (2019-2030)
12.2.3 MEALA Opioids Drug Price by Application (2019-2030)
12.3 MEALA Opioids Drug Market Size by Country
12.3.1 MEALA Opioids Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Opioids Drug Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Opioids Drug Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Opioids Drug Value Chain Analysis
13.1.1 Opioids Drug Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Opioids Drug Production Mode & Process
13.2 Opioids Drug Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Opioids Drug Distributors
13.2.3 Opioids Drug Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Opioids Drug Market by Type
1.2.1 Global Opioids Drug Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Opioids Drug Market by Application
1.3.1 Global Opioids Drug Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 OPIOIDS DRUG MARKET DYNAMICS
2.1 Opioids Drug Industry Trends
2.2 Opioids Drug Industry Drivers
2.3 Opioids Drug Industry Opportunities and Challenges
2.4 Opioids Drug Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Opioids Drug Revenue Estimates and Forecasts (2019-2030)
3.2 Global Opioids Drug Revenue by Region
3.2.1 Global Opioids Drug Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Opioids Drug Revenue by Region (2019-2024)
3.2.3 Global Opioids Drug Revenue by Region (2025-2030)
3.2.4 Global Opioids Drug Revenue Market Share by Region (2019-2030)
3.3 Global Opioids Drug Sales Estimates and Forecasts 2019-2030
3.4 Global Opioids Drug Sales by Region
3.4.1 Global Opioids Drug Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Opioids Drug Sales by Region (2019-2024)
3.4.3 Global Opioids Drug Sales by Region (2025-2030)
3.4.4 Global Opioids Drug Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Opioids Drug Revenue by Manufacturers
4.1.1 Global Opioids Drug Revenue by Manufacturers (2019-2024)
4.1.2 Global Opioids Drug Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Opioids Drug Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Opioids Drug Sales by Manufacturers
4.2.1 Global Opioids Drug Sales by Manufacturers (2019-2024)
4.2.2 Global Opioids Drug Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Opioids Drug Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Opioids Drug Sales Price by Manufacturers (2019-2024)
4.4 Global Opioids Drug Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Opioids Drug Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Opioids Drug Manufacturers, Product Type & Application
4.7 Global Opioids Drug Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Opioids Drug Market CR5 and HHI
4.8.2 2023 Opioids Drug Tier 1, Tier 2, and Tier
5 OPIOIDS DRUG MARKET BY TYPE
5.1 Global Opioids Drug Revenue by Type
5.1.1 Global Opioids Drug Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Opioids Drug Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Opioids Drug Revenue Market Share by Type (2019-2030)
5.2 Global Opioids Drug Sales by Type
5.2.1 Global Opioids Drug Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Opioids Drug Sales by Type (2019-2030) & (M Units)
5.2.3 Global Opioids Drug Sales Market Share by Type (2019-2030)
5.3 Global Opioids Drug Price by Type
6 OPIOIDS DRUG MARKET BY APPLICATION
6.1 Global Opioids Drug Revenue by Application
6.1.1 Global Opioids Drug Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Opioids Drug Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Opioids Drug Revenue Market Share by Application (2019-2030)
6.2 Global Opioids Drug Sales by Application
6.2.1 Global Opioids Drug Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Opioids Drug Sales by Application (2019-2030) & (M Units)
6.2.3 Global Opioids Drug Sales Market Share by Application (2019-2030)
6.3 Global Opioids Drug Price by Application
7 COMPANY PROFILES
7.1 Teva
7.1.1 Teva Comapny Information
7.1.2 Teva Business Overview
7.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Teva Opioids Drug Product Portfolio
7.1.5 Teva Recent Developments
7.2 Purdue Pharma
7.2.1 Purdue Pharma Comapny Information
7.2.2 Purdue Pharma Business Overview
7.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Purdue Pharma Opioids Drug Product Portfolio
7.2.5 Purdue Pharma Recent Developments
7.3 Mallinckrodt
7.3.1 Mallinckrodt Comapny Information
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mallinckrodt Opioids Drug Product Portfolio
7.3.5 Mallinckrodt Recent Developments
7.4 Amneal Pharma
7.4.1 Amneal Pharma Comapny Information
7.4.2 Amneal Pharma Business Overview
7.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Amneal Pharma Opioids Drug Product Portfolio
7.4.5 Amneal Pharma Recent Developments
7.5 Collegium
7.5.1 Collegium Comapny Information
7.5.2 Collegium Business Overview
7.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Collegium Opioids Drug Product Portfolio
7.5.5 Collegium Recent Developments
7.6 J&J
7.6.1 J&J Comapny Information
7.6.2 J&J Business Overview
7.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 J&J Opioids Drug Product Portfolio
7.6.5 J&J Recent Developments
7.7 Endo
7.7.1 Endo Comapny Information
7.7.2 Endo Business Overview
7.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Endo Opioids Drug Product Portfolio
7.7.5 Endo Recent Developments
7.8 Pfizer
7.8.1 Pfizer Comapny Information
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Pfizer Opioids Drug Product Portfolio
7.8.5 Pfizer Recent Developments
7.9 INSYS
7.9.1 INSYS Comapny Information
7.9.2 INSYS Business Overview
7.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 INSYS Opioids Drug Product Portfolio
7.9.5 INSYS Recent Developments
7.10 Mylan
7.10.1 Mylan Comapny Information
7.10.2 Mylan Business Overview
7.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Mylan Opioids Drug Product Portfolio
7.10.5 Mylan Recent Developments
7.11 Hikma
7.11.1 Hikma Comapny Information
7.11.2 Hikma Business Overview
7.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Hikma Opioids Drug Product Portfolio
7.11.5 Hikma Recent Developments
7.12 Egalet
7.12.1 Egalet Comapny Information
7.12.2 Egalet Business Overview
7.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Egalet Opioids Drug Product Portfolio
7.12.5 Egalet Recent Developments
8 NORTH AMERICA
8.1 North America Opioids Drug Market Size by Type
8.1.1 North America Opioids Drug Revenue by Type (2019-2030)
8.1.2 North America Opioids Drug Sales by Type (2019-2030)
8.1.3 North America Opioids Drug Price by Type (2019-2030)
8.2 North America Opioids Drug Market Size by Application
8.2.1 North America Opioids Drug Revenue by Application (2019-2030)
8.2.2 North America Opioids Drug Sales by Application (2019-2030)
8.2.3 North America Opioids Drug Price by Application (2019-2030)
8.3 North America Opioids Drug Market Size by Country
8.3.1 North America Opioids Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Opioids Drug Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Opioids Drug Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Opioids Drug Market Size by Type
9.1.1 Europe Opioids Drug Revenue by Type (2019-2030)
9.1.2 Europe Opioids Drug Sales by Type (2019-2030)
9.1.3 Europe Opioids Drug Price by Type (2019-2030)
9.2 Europe Opioids Drug Market Size by Application
9.2.1 Europe Opioids Drug Revenue by Application (2019-2030)
9.2.2 Europe Opioids Drug Sales by Application (2019-2030)
9.2.3 Europe Opioids Drug Price by Application (2019-2030)
9.3 Europe Opioids Drug Market Size by Country
9.3.1 Europe Opioids Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Opioids Drug Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Opioids Drug Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Opioids Drug Market Size by Type
10.1.1 China Opioids Drug Revenue by Type (2019-2030)
10.1.2 China Opioids Drug Sales by Type (2019-2030)
10.1.3 China Opioids Drug Price by Type (2019-2030)
10.2 China Opioids Drug Market Size by Application
10.2.1 China Opioids Drug Revenue by Application (2019-2030)
10.2.2 China Opioids Drug Sales by Application (2019-2030)
10.2.3 China Opioids Drug Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Opioids Drug Market Size by Type
11.1.1 Asia Opioids Drug Revenue by Type (2019-2030)
11.1.2 Asia Opioids Drug Sales by Type (2019-2030)
11.1.3 Asia Opioids Drug Price by Type (2019-2030)
11.2 Asia Opioids Drug Market Size by Application
11.2.1 Asia Opioids Drug Revenue by Application (2019-2030)
11.2.2 Asia Opioids Drug Sales by Application (2019-2030)
11.2.3 Asia Opioids Drug Price by Application (2019-2030)
11.3 Asia Opioids Drug Market Size by Country
11.3.1 Asia Opioids Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Opioids Drug Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Opioids Drug Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Opioids Drug Market Size by Type
12.1.1 MEALA Opioids Drug Revenue by Type (2019-2030)
12.1.2 MEALA Opioids Drug Sales by Type (2019-2030)
12.1.3 MEALA Opioids Drug Price by Type (2019-2030)
12.2 MEALA Opioids Drug Market Size by Application
12.2.1 MEALA Opioids Drug Revenue by Application (2019-2030)
12.2.2 MEALA Opioids Drug Sales by Application (2019-2030)
12.2.3 MEALA Opioids Drug Price by Application (2019-2030)
12.3 MEALA Opioids Drug Market Size by Country
12.3.1 MEALA Opioids Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Opioids Drug Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Opioids Drug Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Opioids Drug Value Chain Analysis
13.1.1 Opioids Drug Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Opioids Drug Production Mode & Process
13.2 Opioids Drug Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Opioids Drug Distributors
13.2.3 Opioids Drug Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
